
A method for parallel assembly of a large number of peptide-therapeutic cargo combinations, developed by Mike Gait’s group in the LMB’s PNAC Division, has been licensed to Cambridge Research Biochemicals (CRB). The company aims to launch a service in October to provide both researchers and pharmaceutical companies with custom-made libraries of peptide-cargo conjugates to help accelerate the delivery and development of new therapeutics.